Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.50 |
| ▸ | RHEB | Q15382 | 9/20 | 0.47 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.40 |
| ▸ | HTR6 | P50406 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.37 |
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | ITGB2 | P05107 | 1/20 | 0.37 |
| ▸ | ICAM1 | P05362 | 1/20 | 0.37 |
| ▸ | ITGAL | P20701 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | ADK | P55263 | 1/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.36 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5720513 | 0.81 | AHR (0.57) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL826095 | 0.79 | AXL (0.52) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL30225674 | 0.79 | AXL (0.52) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL2607555 | 0.79 | AHR (0.50) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL23051024 | 0.76 | AHR (0.47) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL30720217 | 0.76 | AHR (0.47) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL27437897 | 0.76 | AHR (0.47) | AHRRHEBPIK3CDMAPK1ADRB1 | |
| SCHEMBL73057 | 0.76 | RHEB (0.61) | AHRRHEBPIK3CDGAAMAPT | |
| SCHEMBL29557397 | 0.76 | RHEB (0.61) | AHRRHEBPIK3CDGAAMAPT | |
| SCHEMBL10264079 | 0.75 | AHR (0.46) | AHRRHEBPIK3CDMAPK1ADRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12612548-B2 | Method for producing inorganic fluoride luminescent material | NICHIA CORPORATION (JP) | 2026-04-28 | — | — | US | disclosed |
| US-20230220275-A1 | METHOD FOR PRODUCING INORGANIC FLUORIDE LUMINESCENT MATERIAL | NICHIA CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-20230142294-A1 | PRODUCTION METHOD OF INORGANIC FLUORIDE LUMINESCENT MATERIAL | NICHIA CORPORATION (JP) | 2023-05-11 | — | — | US | disclosed |
| EP-1072576-B1 | FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | MITSUI CHEMICALS INC (JP) | 2006-08-02 | — | — | EP | disclosed |
| US-6417361-B1 | HYDROGEN FLUORIDE AND N,N'-DIALKYLCYCLIC UREA COMPOUND | MITSUI CHEMICALS, INC. (JP) | 2002-07-09 | — | — | US | disclosed |
| CN-1294568-A | Fluorinating agent, process for producing same, and use thereof | MITSUI CHEMICALS INC (JP) | 2001-05-09 | — | — | CN | disclosed |
| EP-1072576-A1 | FLUORINATING AGENT, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Mitsui Chemicals, Inc. (JP) | 2001-01-31 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12612548-B2 | Method for producing inorganic fluoride luminescent material | FLNA, F7, NPM1 | AHR 3880/4885RHEB 2116/4885PIK3CD 531/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.